Covered recipient · General Payments record
RYAN S WANG
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2024
$1,544.98
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $883.76 | 6 |
| Food and Beverage | $661.22 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $1,100.69 | 8 |
| ABBVIE INC. | $180.91 | 7 |
| W. L. Gore & Associates, Inc. | $143.47 | 1 |
| Amneal Pharmaceuticals LLC | $119.91 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $1,544.98 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $394.54 | 08/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125431379 | CMS |
| Abbott Laboratories | $157.54 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125248438 | CMS |
| Abbott Laboratories | $59.39 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125248442 | CMS |
| Abbott Laboratories | $125.46 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125431369 | CMS |
| Abbott Laboratories | $53.62 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125431371 | CMS |
| Abbott Laboratories | $78.67 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125431373 | CMS |
| Abbott Laboratories | $222.45 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125431375 | CMS |
| Abbott Laboratories | $9.02 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125431377 | CMS |
| ABBVIE INC. | $100.97 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106306607 | CMS |
| ABBVIE INC. | $30.67 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106306609 | CMS |
| ABBVIE INC. | $6.48 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106306611 | CMS |
| ABBVIE INC. | $6.21 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106306613 | CMS |
| ABBVIE INC. | $6.81 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106306615 | CMS |
| ABBVIE INC. | $5.22 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106306617 | CMS |
| ABBVIE INC. | $24.55 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106306619 | CMS |
| Amneal Pharmaceuticals LLC | $119.91 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139205176 | CMS |
| W. L. Gore & Associates, Inc. | $143.47 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148112328 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.